This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Astellas Pharma Gmbh, Chemo-Sero-Therapeutic Research Institute. Active years: 2007-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2007)
- Chuo-ku, JP (2010)
- Tokyo, JP (2013 - 2014)
Company Filing History:
3 out of 424 
3 out of 151 Years Active: 2007-2014
Title: Nobuchika Yamamoto: Innovator in Antibody Development
Introduction
Nobuchika Yamamoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 4 patents to his name, his work has the potential to impact various medical treatments.
Latest Patents
Yamamoto's latest patents include a human anti-α9 integrin antibody. This invention provides an antibody or an antibody fragment that specifically recognizes human α9 integrin and mouse α9 integrin. It inhibits the interaction with their ligands, particularly focusing on loop regions of these integrins. Additionally, it includes a gene encoding the antibody or fragment, a recombinant expression vector, and a method for producing the antibody or fragment. This invention also proposes an agent for the prophylaxis or treatment of rheumatoid arthritis. Another notable patent is the humanized anti-human α9-integrin antibody. This invention offers improved activity and properties compared to a donor mouse anti-human α9 integrin antibody. It includes specific amino acid sequences for heavy-chain and light-chain variable regions, which are crucial for the antibody's function in treating diseases involving human α9 integrin.
Career Highlights
Throughout his career, Yamamoto has worked with notable organizations such as the Juridical Foundation the Chemo-Sero-Therapeutic Research Institute and Astellas Pharma GmbH. His experience in these institutions has allowed him to refine his expertise in antibody research and development.
Collaborations
Yamamoto has collaborated with esteemed colleagues, including Hirofumi Higuchi and Toshihiro Nakashima. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Nobuchika Yamamoto is a distinguished inventor whose work in antibody development holds promise for medical advancements. His innovative patents and collaborations reflect his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile